Home
>
National Drug Code (NDC)
>
Benzaclin
Benzaclin - 0187-5190-25 - (Clindamycin phosphate and benzoyl peroxide)
Drug Information of Benzaclin
| Product NDC: | 0187-5190 |
| Proprietary Name: | Benzaclin |
| Non Proprietary Name: | Clindamycin phosphate and benzoyl peroxide |
| Active Ingredient(s): | 50; 10 mg/g; mg/g & nbsp; Clindamycin phosphate and benzoyl peroxide |
| Administration Route(s): | TOPICAL |
| Dosage Form(s): | GEL |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Benzaclin
| Product NDC: | 0187-5190 |
| Labeler Name: | Valeant Pharmaceuticals North America LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA050756 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20130531 |
Package Information of Benzaclin
| Package NDC: | 0187-5190-25 |
| Package Description: | 1 JAR in 1 CARTON (0187-5190-25) > 25 g in 1 JAR |
NDC Information of Benzaclin
| NDC Code | 0187-5190-25 |
| Proprietary Name | Benzaclin |
| Package Description | 1 JAR in 1 CARTON (0187-5190-25) > 25 g in 1 JAR |
| Product NDC | 0187-5190 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Clindamycin phosphate and benzoyl peroxide |
| Dosage Form Name | GEL |
| Route Name | TOPICAL |
| Start Marketing Date | 20130531 |
| Marketing Category Name | NDA |
| Labeler Name | Valeant Pharmaceuticals North America LLC |
| Substance Name | BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE |
| Strength Number | 50; 10 |
| Strength Unit | mg/g; mg/g |
| Pharmaceutical Classes | Decreased Sebaceous Gland Activity [PE],Lincosamide Antibacterial [EPC],Lincosamides [Chemical/Ingredient] |
